Axial spondyloarthritis - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Axial Spondyloarthritis – Comprehensive Medical Guide

Overview

Axial spondyloarthritis (axSpA) is a chronic, inflammatory rheumatic disease that primarily affects the spine and the sacroiliac joints (the joints where the spine meets the pelvis). It belongs to a family of disorders called spondyloarthritides, which also includes psoriatic arthritis, reactive arthritis, and enteropathic arthritis.

AxSpA can present in two forms:

  • Radiographic axSpA (Ankylosing Spondylitis) – structural changes are visible on standard X‑rays.
  • Non‑radiographic axSpA – inflammation is present, but X‑rays are still normal; the disease is usually diagnosed with MRI.

The condition typically begins in late adolescence or early adulthood, with 80 % of cases starting before age 40. Men are affected about twice as often as women, though the gender gap narrows in non‑radiographic disease.[1] CDC, 2023

Global prevalence estimates range from 0.2 % to 1.4 % of the population, making axSpA one of the more common inflammatory arthritis disorders.[2] WHO, 2022

Symptoms

Symptoms can vary widely and may evolve over time. Early signs are often subtle, which can delay diagnosis.

Back‑related symptoms

  • Inflammatory back pain – pain that improves with activity and worsens after periods of rest; usually felt in the lower back or buttocks.
  • Morning stiffness – lasting >30 minutes, improves after 10–15 minutes of movement.
  • Enthesitis – inflammation where tendons or ligaments attach to bone (e.g., at the heels, hips, or ribs).
  • Reduced spinal mobility – difficulty bending forward, turning the torso, or performing daily activities.

Peripheral joint involvement

  • Swelling and pain in the hips, shoulders, knees, or ankles.

Extra‑articular manifestations

  • Uveitis (eye inflammation) – occurs in up to 30 % of patients; can cause redness, pain, and blurred vision.
  • Inflammatory bowel disease (Crohn’s disease or ulcerative colitis) – co‑occurs in 5–10 %.
  • Psoriasis – skin lesions in a minority of patients.
  • Fatigue – often profound and not fully explained by pain alone.

Systemic symptoms

  • Low‑grade fever (rare), weight loss, and general malaise.

Causes and Risk Factors

The exact cause of axSpA is unknown, but research points to a combination of genetic predisposition and environmental triggers.

Genetic factors

  • HLA‑B27 – present in 85‑95 % of patients with ankylosing spondylitis, compared with 6–9 % of the general population.[3] NIH, 2024
  • Other genetic loci (e.g., ERAP1, IL23R) modestly increase risk.

Environmental and lifestyle factors

  • Infections – certain gastrointestinal or genitourinary infections may trigger disease onset in genetically susceptible individuals.
  • Smoking – linked to more severe disease and reduced response to biologic therapy.[4] Cleveland Clinic, 2023
  • Gut microbiome alterations are an emerging area of investigation.

Who is at higher risk?

  • First‑degree relatives with ankylosing spondylitis or other spondyloarthritides.
  • Male sex (especially for radiographic disease).
  • Positive HLA‑B27 test.
  • Smoking history.

Diagnosis

Diagnosing axSpA involves a careful history, physical examination, imaging, and laboratory testing. The Assessment of SpondyloArthritis International Society (ASAS) criteria (2009) are widely used.

Clinical evaluation

  • History of inflammatory back pain lasting >3 months, onset before age 45.
  • Presence of at least one “spondyloarthritis feature” (e.g., uveitis, psoriasis, IBD, positive family history, HLA‑B27).

Imaging studies

  • X‑ray of the sacroiliac joints – detects erosions, sclerosis, or ankylosis (radiographic axSpA).
  • MRI – gold standard for early disease; shows bone‑marrow edema and active inflammation even when X‑ray is normal.
  • CT scans are occasionally used for detailed assessment of spinal fusion.

Laboratory tests

  • HLA‑B27 typing – supportive but not diagnostic alone.
  • Acute‑phase reactants (CRP, ESR) – elevated in many patients, correlating with disease activity.
  • Rheumatoid factor (RF) and anti‑CCP antibodies – usually negative, helping to exclude rheumatoid arthritis.

Additional assessments

  • Bone density testing (DXA) – chronic inflammation can lead to osteoporosis.
  • Pulmonary function tests – in advanced disease, chest expansion may be limited.

Treatment Options

Management is aimed at relieving pain, preserving spinal mobility, preventing structural damage, and improving quality of life. A treat‑to‑target approach using validated disease activity scores (e.g., BASDAI, ASDAS) guides therapy.

Medications

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) – first‑line for pain and stiffness. Continuous use may slow radiographic progression in some patients.[5] Mayo Clinic, 2023
  • Biologic disease‑modifying antirheumatic drugs (bDMARDs)
    • TNF‑α inhibitors (e.g., etanercept, adalimumab, infliximab, golimumab, certolizumab).
    • IL‑17 inhibitors (e.g., secukinumab, ixekizumab) – effective especially in patients who fail TNF blockers.
  • Targeted synthetic DMARDs (tsDMARDs) – Janus kinase (JAK) inhibitors (e.g., upadacitinib, tofacitinib) approved for axSpA in many regions.
  • Conventional synthetic DMARDs (e.g., sulfasalazine) – limited role; may help peripheral joint involvement.
  • Corticosteroids – short courses for flares; systemic long‑term use discouraged due to side effects.

Physical and rehabilitative therapies

  • Exercise program – daily stretching, thoracic extension, and aerobic activity (e.g., swimming, walking).
  • Physical therapy – supervised sessions focusing on posture, core strengthening, and breathing exercises.
  • Occupational therapy – ergonomic advice for work and home environments.

Surgical interventions

  • Joint replacement (hip or knee) for severe peripheral arthritis.
  • Spinal osteotomy or corrective surgery in rare cases of severe spinal deformity.

Lifestyle and supportive measures

  • Smoking cessation – improves response to biologics and slows disease progression.
  • Adequate calcium and vitamin D intake; weight‑bearing exercise to protect bone health.
  • Stress management and adequate sleep – chronic pain can exacerbate fatigue.

Living with Axial Spondyloarthritis

Long‑term disease control is possible with the right combination of medication, exercise, and self‑care.

Daily management tips

  • Stay active – Aim for at least 30 minutes of low‑impact aerobic activity most days.
  • Morning routine – Gentle stretching immediately after waking helps reduce stiffness.
  • Posture awareness – Use supportive chairs, avoid prolonged sitting, and keep the computer screen at eye level.
  • Heat therapy – Warm showers, heating pads, or warm baths can relax tense muscles.
  • Regular follow‑up – Track disease activity scores and discuss medication side effects with your rheumatologist every 3–6 months.
  • Support networks – Join patient groups (e.g., Spondylitis Association of America) for peer support and up‑to‑date information.

Managing flares

During a flare, increase NSAID use (as tolerated), apply heat, and consider a short course of oral steroids under physician supervision. If flares become frequent despite optimal therapy, discuss escalation to biologic or JAK‑inhibitor therapy.

Work and productivity

  • Discuss reasonable accommodations with your employer (flexible hours, ergonomic workstation).
  • Consider remote work options during periods of high pain or fatigue.

Travel considerations

  • Carry medication in original packaging; keep a copy of prescriptions.
  • Plan for rest breaks and stretch every 1–2 hours on long trips.
  • Stay hydrated and avoid prolonged immobility to reduce stiffness.

Prevention

Because axSpA has a strong genetic component, primary prevention is limited. However, modifiable risk factors can be addressed:

  • Do not smoke – Smoking is the most consistent modifiable risk factor for disease severity.
  • Maintain a healthy weight – Reduces stress on the spine and improves response to therapy.
  • Prompt treatment of infections – Early eradication of gastrointestinal or genitourinary infections may lower the trigger potential.
  • Regular physical activity – Helps preserve spinal flexibility and may delay structural damage.

Complications

If left uncontrolled, axial spondyloarthritis can lead to serious health problems:

  • Spinal fusion (ankylosis) – Can cause a rigid, “bamboo spine,” limiting chest expansion and mobility.
  • Fractures – Osteoporotic vertebral fractures are more common due to chronic inflammation and reduced mobility.
  • Cardiovascular disease – Inflammation increases risk of atherosclerosis; patients have a higher incidence of hypertension and heart disease.
  • Uveitis – Recurrent eye inflammation may threaten vision if untreated.
  • Reduced lung capacity – Restrictive pattern from limited chest wall expansion.
  • Psychological impact – Chronic pain and functional limitation can lead to anxiety, depression, and decreased quality of life.

When to Seek Emergency Care

Immediate medical attention is needed if you experience any of the following:
  • Sudden, severe chest or back pain that does not improve with rest or medication – could indicate a fracture, spinal cord compression, or aortic involvement.
  • Rapid loss of vision, eye pain, or redness – possible acute uveitis or ocular emergency.
  • New weakness, numbness, or tingling in the legs or arms – signs of spinal cord or nerve root compression.
  • High fever (>38.5 °C / 101.3 °F) with chills, especially if accompanied by severe joint swelling – may signal infection or an inflammatory flare needing aggressive treatment.
  • Shortness of breath or difficulty breathing – could be related to limited chest expansion or a cardiovascular event.

Call 911 or go to the nearest emergency department if any of these symptoms occur.

References

  1. Centers for Disease Control and Prevention. “Spondyloarthritis Fact Sheet.” 2023. https://www.cdc.gov/arthritis/basics/spondyloarthritis.htm
  2. World Health Organization. “Global Burden of Rheumatic Diseases.” 2022. https://www.who.int/health-topics/rheumatic-diseases
  3. National Institutes of Health. “HLA‑B27 and Ankylosing Spondylitis.” 2024. https://www.ncbi.nlm.nih.gov/gtr/conditions/ANKYLOSING-SPONDYLITIS/
  4. Cleveland Clinic. “Smoking and Spondyloarthritis.” 2023. https://my.clevelandclinic.org/health/diseases/21041-ankylosing-spondylitis
  5. Mayo Clinic. “Ankylosing Spondylitis Treatment.” 2023. https://www.mayoclinic.org/diseases-conditions/ankylosing-spondylitis/diagnosis-treatment/drc-20354869
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References